University at Albany - SUNY
Albany, New York, 12222, United States
NCT Number: NCT00069420
This study will evaluate the effectiveness of cognitive motivational behavior therapy (CMBT) in treating pathological gamblers.
Looking for future studies?
Notify Me17 year and older
All sexes
Interventional
Phase 1
Albany, New York, 12222, United States
Pathological gambling is developing into a serious public health problem. The rise in gambling problems has stimulated treatment studies, but little progress has been made. A particular concern is the high dropout rates from treatment studies; gamblers often seek treatment, but fail to complete it and relapse. This study will test the effectiveness of CMBT in helping to increase retention rates in gambling treatment studies.
The first step in this study is designed to enhance gamblers' readiness for change. When participants are committed to change, CMBT will then address specific cognitive biases regarding the notion of randomness, which is thought to lie at the heart of gambling problems. Behavioral components will also be used to enhance gamblers' coping skills.
The participants in this study will be randomly assigned to either CMBT or a Gambler's Anonymous control group. Participants will be assessed prior to and after treatment and at 3- and 6-month follow-up visits. Interviews and questionnaires will be used to assess participants.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
University at Albany
Other
Cognitive-Motivational Behavior Therapy for Gamblers
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02841566
Behavior, Disruptive, Impulse Control, and Conduct Disorders
Nantes, France
View Trial DetailsNCT05241041
Behavior, Behavioral Symptoms
Incheon, South Korea
View Trial DetailsNCT04714008
Behavior, COVID-19
Nantes, France
View Trial DetailsNCT07162220
Behavior, Child, Only
Antalya, Konyaaltı, Turkey (Türkiye)
View Trial Details